{"result": "{\n    \"title\": \"Vasopressin and Norepinephrine in Septic Shock Trials\",\n    \"summary\": \"This community focuses on the clinical trials involving vasopressin and norepinephrine as treatments for septic shock. The trials were conducted across multiple countries, including Canada, Australia, and the United States, and aimed to evaluate the efficacy and safety of these vasopressors. The trials also explored the side effects associated with these treatments, such as mesenteric ischemia and skin necrosis.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of septic shock treatment and the potential implications of the trial findings on clinical practices.\",\n    \"findings\": [\n        {\n            \"summary\": \"Vasopressin's role in septic shock treatment\",\n            \"explanation\": \"Vasopressin was a central focus in the multicenter, randomized, double-blind trial aimed at evaluating its effect on mortality in patients with septic shock. It was administered as a low-dose infusion to manage septic shock and reduce the dosage of norepinephrine. Additionally, vasopressin served as a vasopressor agent used as rescue therapy in the trial [Data: Entities (331); Relationships (178, 496, 447, 806, 820)].\"\n        },\n        {\n            \"summary\": \"Comparison of norepinephrine and vasopressin\",\n            \"explanation\": \"Norepinephrine, a potent α-adrenergic catecholamine vasopressor, was compared with vasopressin in clinical trials for managing septic shock. The trials aimed to evaluate the effectiveness of norepinephrine in managing this critical condition, with a focus on its impact on mortality. Norepinephrine is associated with fewer arrhythmic events compared to dopamine, making it a preferred choice in certain clinical scenarios [Data: Entities (323); Relationships (179, 448, 806, 807)].\"\n        },\n        {\n            \"summary\": \"Adverse effects associated with vasopressin and norepinephrine\",\n            \"explanation\": \"The trials identified several adverse effects associated with the use of vasopressin and norepinephrine. Vasopressin was linked to conditions such as mesenteric ischemia, skin necrosis, digital ischemia, and hyponatremia. Norepinephrine was also associated with mesenteric ischemia and skin necrosis, as well as a higher incidence of cardiac arrests compared to vasopressin [Data: Entities (677, 679, 680, 678); Relationships (821, 823, 824, 822, 808, 809, 807)].\"\n        },\n        {\n            \"summary\": \"Geographical scope of the trials\",\n            \"explanation\": \"The vasopressin trials were conducted in multiple countries, including Canada, Australia, and the United States. This wide geographical scope highlights the international collaboration and the significance of the research in understanding the treatment of septic shock across different healthcare settings [Data: Entities (217); Relationships (79, 239, 652)].\"\n        },\n        {\n            \"summary\": \"Dopamine's role and comparison in shock treatment\",\n            \"explanation\": \"Dopamine, another vasopressor agent, was utilized in the treatment of shock and was part of the clinical trials. It is associated with an increased incidence of arrhythmic events and higher mortality rates in certain subgroups of patients. The trials found no significant difference in mortality between dopamine and norepinephrine in patients with septic shock, highlighting the need for careful consideration of vasopressor choice in clinical practice [Data: Entities (322); Relationships (146, 493, 801, 802)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n331,VASOPRESSIN,\"VASOPRESSIN is a hormone that was the focus of a multicenter, randomized, double-blind trial aimed at evaluating its effect on mortality in patients with septic shock. In this study, vasopressin was administered as a low-dose infusion to manage septic shock and reduce the dosage of norepinephrine. Additionally, vasopressin served as a vasopressor agent used as rescue therapy in the trial.\",13\n323,NOREPINEPHRINE,\"Norepinephrine is a potent α-adrenergic catecholamine vasopressor used in the treatment of shock, particularly septic shock. It is commonly compared with vasopressin in clinical trials for managing septic shock. Norepinephrine is associated with fewer arrhythmic events compared to dopamine, making it a preferred choice in certain clinical scenarios. The use of norepinephrine in these studies follows specific dosing guidelines to ensure efficacy and safety.\",10\n322,DOPAMINE,Dopamine is a vasopressor agent utilized in the treatment of shock. It is associated with an increased incidence of arrhythmic events and higher mortality rates in certain subgroups of patients.,7\n326,SHOCK,,4\n217,CANADA,\"Canada was one of the countries where both the study and the trial were conducted, with multiple centers participating in the research efforts.\",2\n681,CARDIAC ARREST,,2\n677,MESENTERIC ISCHEMIA,\"Mesenteric ischemia is a potential adverse effect associated with vasopressin and norepinephrine, involving reduced blood flow to the intestines\",2\n679,SKIN NECROSIS,\"Skin necrosis is a condition involving the death of skin tissue, reported as a side effect of vasopressin and norepinephrine\",2\n680,DIGITAL ISCHEMIA,\"Digital ischemia is a condition involving reduced blood flow to the fingers or toes, reported more frequently in the vasopressin group\",1\n678,HYPONATREMIA,\"Hyponatremia is a condition of low sodium levels in the blood, reported as a side effect of vasopressin\",1\n661,ISRCTN94845869,The Current Controlled Trials number for the vasopressin study,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n178,SEPTIC SHOCK,VASOPRESSIN,Vasopressin was tested and used as a treatment for patients with septic shock in a clinical trial.,83\n179,SEPTIC SHOCK,NOREPINEPHRINE,\"Norepinephrine is commonly used as a treatment for patients with septic shock. In clinical trials, it has been compared with vasopressin to evaluate its effectiveness in managing this critical condition.\",80\n146,SEPTIC SHOCK,DOPAMINE,No significant difference in mortality was observed between dopamine and norepinephrine in patients with septic shock,77\n496,TRIAL,VASOPRESSIN,Vasopressin was used as rescue therapy in the trial,53\n494,TRIAL,NOREPINEPHRINE,Norepinephrine was one of the vasopressor agents tested in the trial,50\n493,TRIAL,DOPAMINE,Dopamine was one of the vasopressor agents tested in the trial,47\n192,HYDROCORTISONE,NOREPINEPHRINE,Hydrocortisone was administered to patients who received norepinephrine,31\n447,MULTICENTER TRIAL,VASOPRESSIN,The trial was conducted to evaluate the effects of vasopressin on septic shock mortality,29\n191,HYDROCORTISONE,DOPAMINE,Hydrocortisone was administered to patients who received dopamine,28\n448,MULTICENTER TRIAL,NOREPINEPHRINE,The trial was conducted to compare norepinephrine with vasopressin in septic shock treatment,26\n79,AUSTRALIA,VASOPRESSIN,The vasopressin trial was conducted in Australia,26\n239,UNITED STATES,VASOPRESSIN,The vasopressin trial was conducted in the United States,24\n806,NOREPINEPHRINE,VASOPRESSIN,\"The trial investigated the effects of vasopressin and norepinephrine on patients with septic shock, specifically focusing on their impact on mortality. Both vasopressin and norepinephrine were compared in this study to determine their efficacy in treating septic shock.\",23\n801,DOPAMINE,NOREPINEPHRINE,Both dopamine and norepinephrine are used as first-line vasopressor agents in the treatment of shock,17\n816,SHOCK,CONSERVATIVE-STRATEGY GROUP,\"The conservative-strategy group had specific outcomes related to shock, which were compared to those of the liberal-strategy group\",16\n652,CANADA,VASOPRESSIN,The vasopressin trial was conducted in Canada,15\n820,VASOPRESSIN,CARDIAC ARREST,Vasopressin was associated with fewer cardiac arrests compared to norepinephrine in this study,15\n821,VASOPRESSIN,MESENTERIC ISCHEMIA,Vasopressin is associated with the risk of mesenteric ischemia as a side effect,15\n817,SHOCK,LIBERAL-STRATEGY GROUP,\"The liberal-strategy group had specific outcomes related to shock, which were compared to those of the conservative-strategy group\",15\n823,VASOPRESSIN,SKIN NECROSIS,Vasopressin is associated with the risk of skin necrosis as a side effect,15\n824,VASOPRESSIN,DIGITAL ISCHEMIA,Vasopressin is associated with a higher incidence of digital ischemia compared to norepinephrine,14\n822,VASOPRESSIN,HYPONATREMIA,Vasopressin is associated with the risk of hyponatremia as a side effect,14\n819,VASOPRESSIN,ISRCTN94845869,ISRCTN94845869 is the trial number for the vasopressin study,14\n805,NOREPINEPHRINE,SHOCK,Norepinephrine is used as a vasopressor agent in the treatment of shock,14\n645,HIGH-FREQUENCY OSCILLATORY VENTILATION (HFOV),CANADA,Canada was one of the countries where the HFOV study was conducted,12\n807,NOREPINEPHRINE,CARDIAC ARREST,Norepinephrine was associated with more cardiac arrests compared to vasopressin in this study,12\n808,NOREPINEPHRINE,MESENTERIC ISCHEMIA,Norepinephrine is associated with the risk of mesenteric ischemia as a side effect,12\n809,NOREPINEPHRINE,SKIN NECROSIS,Norepinephrine is associated with the risk of skin necrosis as a side effect,12\n802,DOPAMINE,SHOCK,Dopamine is used as a vasopressor agent in the treatment of shock,11\n803,DOPAMINE,CARDIOGENIC SHOCK,Dopamine was associated with an increased rate of death in patients with cardiogenic shock,11\n804,DOPAMINE,HYPOVOLEMIC SHOCK,No significant difference in mortality was observed between dopamine and norepinephrine in patients with hypovolemic shock,11\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}